MCMaria Carazas-Vera

Maria Carazas-Vera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Carazas-Vera has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Virtual and In-Person Psychiatric Care: Appointment Completion and Capacity Use in a Public Mental Health Service in Peru

    by Paulo Ruiz-Grosso, Luis Macedo-Orrego, Diego Rodriguez-Vargas, Maria Rivera-Encinas, Alejandra Arosemena, Maria Carazas-Vera, Abel Sagastegui, Sonia Zevallos-Bustamante

    Objective: To compare appointment completion and offered-slot utilization between virtual and in-person outpatient psychiatric care in Peru. Methods: We conducted a retrospective ecological longitudinal study using routinely collected monthly aggregate administrative indicators from January 2022 through June 2026, with modality-month as the unit. Virtual-minus-in-person differences and 95% confidence intervals used Newey-West standard errors with 12 lags. June 2026 was partial; slot utilization was restricted to 2024-2026. Results: Across 54 paired months, mean completion was 90.9% (SD=3.9) for virtual and 83.8% (SD=2.7) for in-person care; difference +7.2 points (95% CI=4.4-9.9). Across 30 paired months, slot utilization was 73.0% (SD=8.3) and 90.5% (SD=3.8), respectively; difference −17.5 points (95% CI=−24.5 to −10.4). Sensitivity analyses were similar. Conclusions: Virtual care had higher completion but lower slot utilization. Attendance and capacity use should be evaluated separately when planning hybrid psychiatric services. Outpatient psychiatric services increasingly operate as hybrid systems in which virtual and in-person visits coexist.

  • Open Access

    Mental health contact gaps among adults in Peru: a cross-sectional analysis of a nationally representative survey

    by Paulo Ruiz-Grosso, Luis Enrique Macedo Orrego, María Teresa Rivera Encinas, María Soledad Carazas Vera, Diego Mauricio Rodríguez Vargas, Alejandra Arosemena Aliaga, Abel Ampelio Sagástegui Soto, Sonia Zevallos Bustamante

    Objective: To estimate lifetime and 12-month mental health contact gaps among Peruvian adults with survey-defined mental disorders, and to describe inequalities in contact, perceived need for care, and mental health service use. Methods: We analyzed the information for adults of the 2022 Peruvian National Mental Health Survey, a cross-sectional household survey. The primary outcome was the survey-weighted proportion of adults with a 12-month mental disorder who reported no contact with an included source of mental health-related care during that period; the lifetime contact gap was descriptive. Perceived need was assessed using two derived 12-month perceived-need measures based on direct ENSM variables and service-contact routing items. Analyses incorporated weights, strata, and clusters. Adjusted prevalence ratios were estimated using survey-weighted Poisson models. Results: The dataset contained information on 13,840 individuals; 13,833 had complete survey-design information. Contact-gap denominators were 3,927 for lifetime disorders and 1,649 for 12-month disorders. The lifetime and 12-month contact gaps were 61.0% (95% CI 58.4–63.7) and 84.5% (95% CI 81.5–87.6), respectively. Rural estimates exceeded urban estimates in both periods; after adjustment, poverty and rural residence were associated with the lifetime gap, and extreme poverty with the 12-month gap. Among individuals meeting survey-based criteria for one or more 12-month mental disorders, 37.3% (95% CI 33.4–41.4) reported self-perceived need, whereas 25.6% (95% CI 21.8–29.8) reported that need had been identified by others. Annual psychological and psychiatric service use was 3.7% and 1.1%, respectively. Conclusions: Mental health contact gaps were high, particularly for one or more 12-month mental disorders, and were associated with social and territorial variables. These contact measures do not establish adequate, continuous, or effective treatment; which need to be addressed to understand the impact of the Peruvian mental health reform.

  • Open Access

    Revisión actualizada de recomendaciones para el tratamiento de la esquizofrenia en un instituto especializado: enfoque en terapias farmacológicas y psicosociales

    by Joshep Revilla-Zúñiga, Abel Sagástegui-Soto, María Carazas-Vera, Alfredo Saavedra-Castillo

    La esquizofrenia es un trastorno mental complejo y heterogéneo. El artículo presenta una revisión actualizada de las principales recomendaciones farmacológicas y psicosociales en el manejo de los pacientes adultos con esquizofrenia en un establecimiento de salud de nivel III-2 en el Perú. Se trata de una revisión no sistemática de la literatura en PubMed/MEDLINE, Scopus, EMBASE, Cochrane Library, Science Direct y Google Scholar. La esquizofrenia en el adulto requiere el abordaje farmacológico con antipsicóticos que pueden ser usados por vía oral, vía parenteral de acción rápida o vía parenteral de acción prolongada. Antes de su inicio y durante el tratamiento, se recomiendan exámenes basales periódicos. El uso de escalas permite evaluar la respuesta antipsicótica. Se recomienda evaluar regularmente los efectos colaterales/adversos de estos psicofármacos, tales como los síntomas extrapiramidales. Para el tratamiento de la esquizofrenia refractaria, se recomienda el uso de clozapina. En el abordaje psicoterapéutico, destaca la terapia cognitivo-conductual en sus modalidades individual y grupal. El manejo de la esquizofrenia requiere un abordaje farmacológico individualizado y otro, no farmacológico, que involucre a la persona y su contexto social.